Life Science News

Utah Medical Products (Nasdaq:UTMD) concluded an outstanding year in 2017 in which it harvested distribution changes that had been in the making for several years. As quoted in the press release: Although UTMD substantially exceeded management expectations for 2017 financial performance, the results became masked by the recognition of a one-time U.S. repatriation tax (REPAT) …

Utah Medical Products (Nasdaq:UTMD) concluded an outstanding year in 2017 in which it harvested distribution changes that had been in the making for several years.
As quoted in the press release:

Although UTMD substantially exceeded management expectations for 2017 financial performance, the results became masked by the recognition of a one-time U.S. repatriation tax (REPAT) on foreign subsidiary cash and cumulative earnings (E&P) in the fourth quarter (4Q) of the year.

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20063.13-118.79
TSXV696.31-9.27
DOW30895.54-357.59
S&P 5003846.33-54.46
NASD11154.15-234.35
ASX7064.50-118.20

COMMODITIES

Commodities
Gold1842.98+0.80
Silver21.69-0.21
Copper4.280.00
Palladium1962.50-41.50
Platinum954.00-5.00
Oil112.70+0.49
Heating Oil3.63-0.04
Natural Gas8.11-0.20

DOWNLOAD FREE REPORTS

×